Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
Oral Glucokinase Activator Gets Breakthrough Tx Status for Type 1 Diabetes
Trial Evaluating Dapagliflozin in Hospitalized COVID-19 Patients Misses Endpoints
Ozempic Injection 1mg Now Available as a Single Monthly Pen
Aflibercept Cuts Vision-Threatening Complications of Diabetic Retinopathy
More Tepezza Will Be Available Starting in April
SGLT2 Inhibitor Use Linked to Reduced Risk of Atrial Arrhythmias in T2DM Patients
Zegalogue Approved for Severe Hypoglycemia in Patients With Diabetes
Common Meds Interfere With TFTs in Older Adults on Thyroid Hormone
Albuminuria Reduction Greater With SGLT2 Inhibitor, ERA Combo
USPSTF Urges Prediabetes, T2DM Screen for Overweight Adults
Pancreatic Islet Replacement Therapy Fast Tracked for Type 1 Diabetes
Semaglutide May Aid Weight Loss in Obese Patients With T2DM
Tirzepatide Superior to Semaglutide in Head-to-Head Type 2 Diabetes Study
Provider Teams Outperform Solo Care for New-Onset Chronic Disease
Thyquidity Oral Solution Now Available for Hypothyroidism
USPSTF Advises Screening for Gestational Diabetes Mellitus
Significant HbA1c, Body Weight Reductions With Tirzepatide in T2D Studies
